top of page

Advisors & Collaborators

Bringing together a highly experienced, multidisciplinary bio/med-tech team with a proven track record of successful platform & commercial market development.

William Gormley, MD, MPH, MBA.jpg

Co-founder, Neurosurgical Advisor

William Gormley, MD, MPH, MBA

Director, Neurosurgical Critical Care. Brigham & Women's Hospital. Harvard Medical School

priya-kumthekar-md_edited.png

Chair CAB, Neuro-Oncology Advisor

Priya Kumthekar, MD

11426.jpg

Clinical Advisor, Neurodegenerative Disease

Merit Cudkowicz, MD

Chief, Neurology Department
Director, Sean M. Healey & AMG Center for ALS
Julieanne Dorn Professor of Neurology, Harvard Medical School

seema-nagpal_profilephoto.jpg

Clinical Advisor, Oncology

Seema Nagpal, MD

Clinical Associate Professor, Neurology & Neurological Sciences

Clinical Associate Professor, Neurosurgery

Member, Stanford Cancer Institute

Stanford Health Care

heather-gray-edwards.png.jpeg

Pre-Clinical Advisor

Heather Gray-Edwards, PhD, DVM

Assistant Professor, University of Massachusetts Medical School

csm_994_1637471667_1d373cef10.jpeg

Clinical Advisor, Oncology

Priscilla Brastrianos, MD

Associate Professor, Medicine, Harvard Medical School

Assistant Physician in Medicine, Hematology/Oncology, Massachusetts General Hospital

people-photo-kevin-eggan-square-v3.jpg

Co-founder, Scientific Advisor

Kevin Eggan, PhD

Group Vice President, Head of Research and Early Development. BioMarin

 

Former Professor in the Department of Stem Cell and Regenerative Biology at Harvard University

people-photo-navia-manuel-dda-square.jpg

Co-Foudner, Scientific Advisor

Manuel A. Navia, PhD

President of Hub-Bio Strategic Advising

Executive-in-residence at the venture capital firm Oxford Bioscience Partners in Boston, and is a co-founder of eXIthera Pharmaceuticals

TMC_4301.jpg

Medical Technology Advisor

Greg Martin, PhD

Executive, entrepreneur, engineer and scientist with over 20 years experience taking medical technologies from concept to bedside to commercialization

people-photo-kasper-roet-ceo-square-1.jpg

Co-founder, Therapeutics Advisor

Kasper Roet, PhD

CEO and co-founder of QurAlis Corporation and is also co-founder and serves on the Board of Directors of EnClear Therapies. Kasper is a passionate neuroscientist and patient advocate

©2021 by EnClear Therapies.

bottom of page